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Preconditioning with tin-protoporphyrin IX attenuates ischemia/ versible consequences leading to cellular death, while a
reperfusion injury in the rat kidney. number of mechanisms are involved in cellular protec-
Background. Heme oxygenase (HO)-1 is induced as a unique tion during a recovery phase.stress response and leads to a transient resistance against oxida-
In general, oxidative stress such as chemotherapy andtive damage, including ischemia and reperfusion (I/R) injury.
hypoxia may enhance intracellular accumulation of hemeIn the present study, we examined whether HO-1 induction
may confer a protection against I/R injury in the rat kidney. molecules, which participate in renal cell damage [5].
Methods. Lewis rats were divided into four groups as fol- Under these circumstances, inducible heme oxygenase
lows: (1) vehicle group; (2) group treated with ferri-protopor- (HO)-1 may be rapidly induced after stressful stimuli to
phyrin IX (hemin), an inducer of HO; (3) group treated with
protect renal cells from further degeneration. On thelow-dose tin-protoporphyrin IX (SnPP), an inhibitor of HO; and
other hand, HO-2 is the constitutive form, which is in-(4) group treated with high-dose SnPP. Renal warm ischemia
duced only by glucocorticoids [6]. The protective mecha-for 60 minutes was performed 24 hours after each treatment.
Results. At 24 hours after treatment, hemin induced a signifi- nisms of inducible HO-1 have been implicated in the
cant increase in renal HO activity, but failed to induce HO-1 removal of potentially toxic heme molecules and a lipid-
protein synthesis. Although both low- and high-dose SnPP re- soluble iron from intracellular space, in generation ofduced HO activity, a marked HO-1 expression was observed only
antioxidant bile pigments and vasodilative carbon mon-in the high-dose SnPP-treated kidney. Hemin exacerbated the
oxide, and in concomitant induction of ferritin biosynthe-renal function after reperfusion, while high-dose SnPP signifi-
cantly suppressed the intercellular adhesion molecule (ICAM)-1 sis, which sequesters redox-active iron [7–9]. Therefore,
expression, the infiltration of ED-1–positive macrophages and protective effect of HO-1 induction seems to be depen-
the expression of activated caspase-3, which resulted in attenu- dent on its enzymatic action.
ation of apoptotic cell death and ameliorated I/R injury.
Although it has been reported that prior induction ofConclusion. These results suggest that prior induction of
HO-1 protects the renal cells from subsequent stressfullHO-1 protein by high-dose SnPP may lead to anti-inflamma-
stimuli [10–13], the beneficial effect of HO-1 has nottory and antiapoptotic effects on warm renal I/R injury inde-
pendently of its enzyme activity, and that HO enzyme activation been identified on renal I/R injury [10, 11]. Paradoxically,
may not always act as an antioxidant, especially under I/R- it has been suggested that the defense mechanism of
induced oxidative stress. HO-1 might be mediated by increased induction of HO-1
protein independently of HO enzyme activity [14]. Fur-
thermore, it has been reported that up-regulation of
Renal ischemia followed by reperfusion results in tubu- HO activity worsened cytotoxicity in some experimental
lar epithelial cell injury mediated by oxidative stress [1]. models [15, 16].
Ischemia and reperfusion (I/R) injury may be exacer- HO enzyme activity is up-regulated by its substrate
bated by the release of proinflammatory cytokines, the ferri-protoporphyrin IX (hemin) [7], whereas tin-proto-
expression of adhesion molecules, and cellular infiltra- porphyrin IX (SnPP), a potent competitive inhibitor of
tion [2–4]. Extended exposure to ischemia causes irre- HO, regulates HO by a dual control mechanism; potently
inhibiting the HO enzyme activity while enhancing the
synthesis of HO enzyme protein [17]. Since SnPP com-Key words: heme oxygenase-1, tin-protoporphyrin IX, ischemia and
reperfusion injury, kidney. pletely blocks the activity of both preformed and newly
synthesized enzyme, it acts as an inhibitor of HO in vivo.Received for publication December 31, 2001
Thus, we compared these metalloporphyrins in the pres-and in revised form November 15, 2002
Accepted for publication April 26, 2002 ent study, which was designed to examine whether induc-
ible HO-1 may protect against warm renal I/R injury. 2003 by the International Society of Nephrology
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METHODS ately performed. After 60 minutes of ischemia, the clip
was removed allowing the kidney to reperfuse, and theThe present study was carried out according to the
wound was closed with 3-0 silk. Sham-operated animalsguidelines for care and use of experimental animals, as
underwent isolation of the right renal artery withoutdetermined by the committee of the Research Institute
occlusions, and a left nephrectomy was performed.for Artificial Organs, Transplantation and Gene Ther-
For the measurement of the serum creatinine levelapy, Hokuyu Hospital and Kitasato University School
after reperfusion, 0.5 mL blood sample was collected viaof Medicine.
the tail vein under the anesthetized condition on days 0
(preischemia), 1, 3, 5, and 7 (postischemia), and mea-Animals
sured by automatic analyzer (7150; Hitachi, Tokyo, Ja-Inbred male Lewis rats (190 to 250 g) were bred at our
pan). The kidney tissue samples (N  six per group)laboratory, housed in a climate-controlled room (22 
were taken 24 hours after reperfusion to examine the inter-1C), with a 12 hours light/dark cycle, and given tap
cellular adhesion molecule (ICAM)-1 expression and thewater and standard rat chow (CE-2, CLEA Japan Co.,
infiltration of ED-1–positive macrophages. Apoptosis wasTokyo, Japan).
evaluated with terminal deoxynucleotidyl transferase-
mediated uridine triphosphate nick end labeling (TUNEL)Experimental design
assay and activated caspase-3 immunohistochemistry.The animals were divided into four groups as follows:
(1) vehicle group, which received 4 ml/kg of 0.9% NaCl Reverse transcription-polymerase chain
solution as a vehicle control; (2) ferri-protoporphyrin reaction (RT-PCR)
IX chloride (hemin) group, which received 30 mol/kg
The total RNA was extracted from the kidney tissuehemin (Sigma Chemical Co., St. Louis, MO, USA) as a
specimens by the guanidinium isothiocyanate method aspotent inducer of HO; (3) low-dose tin-protoporphyrin
previously described [19]. In brief, 5 g total RNA wasIX (SnPP) group, which received 2 mol/kg SnPP (Por-
reverse transcripted in cDNA using a commercially
phyrin Products, Logan, UT, USA) as a competitive
available SuperScript preamplification system (GIBCO,
inhibitor of HO enzyme activity; and (4) high-dose SnPP
Life Technologies, Tokyo, Japan). The resulting cDNA
group, which received 20 mol/kg SnPP. Hemin or SnPP
(1 g) was amplified for 30 cycles using primers as fol-
solution was prepared under subdued light by dissolving lows; HO-1 sense (5-TGG AAG AGG AGA TAG
the compound in 1 mL 0.2 N NaCl, adjusting the pH AGC GA-3) and HO-1 antisense (5-TGT TGA GCA
from 7.40 to 7.80 with 1 N HCl, and diluting the solution GGA AGG CGG TC-3). Glyceraldehyde-3-phosphate
to the final volume with 0.9% NaCl. The solution was dehydrogenase (GAPDH) as an internal control was
kept in the dark and used within 1 hour. Doses of hemin obtained from an MPCR kit for rat apoptosis genes set-2
and SnPP used in the present study were selected ac- (Maxim Biotech, Inc., San Francisco, CA, USA). The
cording to previous reports [12, 17, 18]. Fresh kidneys amplification product length was 451 bp. The polymerase
taken from untreated animals were used as a fresh con- chain reaction (PCR) products were separated on a 2%
trol. For examination of protective genes induction agarose gel containing ethidium bromide, and photo-
(HO-1, ferritin, and HSP 70), and HO activity, kidney graphed. Digital photographs were assessed using image
tissue specimens (N  six per group) were harvested 24 analysis software (Luminous Imager, AISIN COSMOS
hours after the treatments and stored at 80C. In the R&D Co., Aichi, Japan) and mRNA expression was
high-dose SnPP groups, the rats were sacrificed at the assessed by the band intensity ratio of HO-1 to GAPDH.
time points indicated in the figures after injection to
Western blot analysisexamine the time courses of HO-1 mRNA and protein
induction. In addition, for the examination of inhibitory The kidney tissues were homogenized in ice-cold lysis
effect of an inhibitor of protein synthesis on HO-1 induc- buffer containing protease inhibitors as described pre-
tion at translational level, 2 mg/kg cycloheximide was viously [20]. The homogenates were centrifuged at 10,000 g
administered intraperitoneally 2 hours before high-dose at 4C for 20 minutes. The resulting supernatants were
SnPP treatment. mixed with sample buffer and boiled for 5 minutes. Sam-
ples containing 100g protein were separated by electro-
Renal model of warm I/R phoresis on 12.5% sodium dodecyl sulfate-polyacrylamide
The animals were anesthetized with ether 24 hours gels (SDS-PAGE) and then transferred to polyvinylidine
after the treatment. Body temperature was maintained difluoride transfer membranes. The membranes were
at 37C by a heating lamp until animals recovered from incubated with either rabbit anti-rat HO-1 polyclonal anti-
anesthesia. The right renal artery was isolated and bodies, rabbit anti-rat HO-2 polyclonal antibodies (1:1000
clamped with a nontraumatic microvascular clip for 60 dilution for HO-1 and 1:2000 dilution for HO-2) (Stress-
Gen Biotech, Victoria, BC), rabbit antihuman ferritinminutes, and a contralateral nephrectomy was immedi-
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antibodies (1:1000 dilution) (DAKO A/S, Glostrup, Den- diaminobenzidine tetrahydrochloride for 2 minutes and
counterstained with methylgreen for 20 minutes. Themark), rabbit anti-rat heat shock protein (HSP) 70 poly-
clonal antibodies (1:5000 dilution) (StressGen Biotech, negative control was prepared by omission of the primary
antibodies. ED-1–positive cells in the outer medulla wereVictoria, BC, Canada) or mouse anti--tubulin mono-
clonal antibodies (1:500 dilution) (Pharmingen, San Diego, counted and expressed as the number of cells per field
of view at a magnification of 400.CA, USA) as an internal control. After washing with
phosphate-buffered saline (PBS) containing 0.05% Tween
Assessment of apoptosis20, the membranes were incubated with horseradish per-
oxidase-conjugated goat antirabbit (1:2000 dilution) Dako TUNEL Assay. Apoptosis was determined using the
in situ end-labeling technique. Formalin-fixed paraffin-Co., Carpinteria, CA, USA) or goat antimouse (1:5000
dilution) (Pierce Chemical Co., Rockford, IL, USA) sec- embedded sections (5 m) of kidney were investigated
using the ApopTag Peroxidase Kit (Intergen Co., Pur-ondary antibodies. Immunoreactive bands were visual-
ized by an enhanced chemiluminescence detection sys- chase, NY, USA). The specimens were deparaffinized
and treated according to the prescription with the pro-tem (Amersham Pharmacia Biotech, Buckinghamshire,
England, UK). The band intensities of ferritin and HSP vided kit components. The peroxidase activity was visu-
alized with 3-amino-9-ethylcarbazole (AEC) substrate,70 were measured by NIH Image Analysis software and
presented in comparison to -tubulin expression. yielding a brown-red oxidation product. Hematoxylin
was used as counterstain.
HO enzyme activity in the whole kidney tissue Immunohistochemistry of activated caspase-3. To fur-
ther assess the involvement of apoptosis, activated cas-The kidney tissues were homogenized and lysed in
0.25 mol/L sucrose lysing buffer containing 0.1 mol/L pase-3 expression was evaluated by using anti-cleaved
caspase-3 polyclonal antibody (Cell Signaling Technol-phenylmethylsulfonyl fluoride. The microsomal fraction
was prepared and used for measurement of the HO en- ogy, Beverly, MA, USA), which detects caspase-3 activa-
tion, a final step of the caspase activation cascade. Thezyme activity as detailed previously [21]. The reaction
mixture contained the following in a final volume of 300 sections were incubated with cleaved caspase-3 antibod-
ies (1:100 dilution), and subsequently incubated with bio-L; 1 mmol/L glucose 6-phosphate, 0.167 U/mL glucose
6-phosphate dehydrogenase, 0.8 mmol/L nicotinamide tinylated goat antirabbit immunoglobulins (1:200 dilu-
tion) (DAKO A/S., Denmark). Then, after the incubationadenine dinucleotide phophate (NADP), 15 mmol/L he-
min, 2 mmol/L MgCl2, 0.01 mg/mL NADPH-cytochrome with a preformed avidin and biotinylated horseradish
peroxidase complex reagent, the immune complex wasP450 reductase, 3.3 mg protein/mL rat liver cytosol, po-
tassium phosphate buffer (pH 7.4), and the supernatant visualized with AEC substrate. The sections were coun-
terstained with hematoxylin.from the tissue specimens (100 L). Incubation was car-
ried out at 37C for 60 minutes in the dark. An equal The number of TUNEL- and activated caspase-3–
positive cells in the outer medulla were counted andvolume of chloroform was added to the reaction mixture,
and amount of bilirubin, which was extracted into the expressed as the number of cells per field of view at a
magnification of 200.chloroform fraction, was determined by the measure-
ment of 	 optical density (OD) between 464 and 530
Statistical analysisnm. Enzyme activity was expressed as pmol of bilirubin
per mg of tissue protein generated over 60 minutes. All data were expressed as mean  SEM. Differences
were analyzed by one-way analysis of variance (ANOVA).
Immunohistochemistry Statistical calculations were performed on a Macintosh
personal computer using the Statview II Statistical Pack-The kidney tissues were embedded in OCT com-
pounds (Tissue-Tek, Sakura Finetek Inc., CA) and quick- age (Abacus Concepts, Berkeley, CA, USA). Significant
difference was taken as P 
 0.05.frozen in liquid nitrogen. Cryostat sections (9 m thick)
were mounted on glass slides. The tissue sections were
exposed to polyclonal rabbit anti-rat HO-1 antibodies
RESULTS
(1:500 dilution), monoclonal mouse anti-rat ICAM-1 an-
Expression of HO isoforms in the kidney tissuestibodies (1:200 dilution, Pharmingen Int., Becton Dickin-
son Co., USA) and monoclonal mouse anti-rat ED-1 First, we compared the expression of HO-1 and HO-2 in
the kidney tissues 24 hours after each treatment. Westernantibodies (1:500 dilution, Serotec Ltd., Oxon, UK) for
60 minutes at room temperature. After washing, the sec- blot analysis indicated that the injection of high-dose
SnPP significantly induced HO-1 expression in the kid-tions were overlaid with peroxidase-conjugated goat
anti-rabbit or anti-mouse secondary antibodies (Dako ney, while there was no effect of hemin and SnPP treat-
ment on HO-2 expression (Fig. 1A). In addition, theEnvision kit/HRP, DAB, Dako Co., CA) for 30 minutes.
Finally, the sections were applied with 0.1 mg/ml of 3,3- HO-1 expression was completely inhibited by adminis-
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Fig. 2. Time course of heme oxygenase (HO-1) mRNA expression inFig. 1. Expression of heme oxygenase (HO) isoforms in the kidney
the kidney tissues after high-dose tin-protoporphyrin IX (SnPP) (20tissues 24 hours after each treatment. Expression of HO-1and HO-2
mol/kg) injection. Expression of HO-1 mRNA in the kidney tissuesprotein in kidney tissues was evaluated by Western blot analysis after
was evaluated by reverse transcription-polymerase chain reaction (RT-injection of vehicle, hemin, low- and high-dose tin-protoporphyrin IX
PCR) analysis (A), and the results were expressed as HO-1/glyceralde-(SnPP) (A). -tubulin was used as an internal control. A prominent
hydes-3-phosphate dehydrogenase (GAPDH) ratios (B) (N  four inexpression of HO-1 protein was detected in the high-dose SnPP-treated
each time). GAPDH was used as an internal control. The expressionkidney alone, although there was no significant increase in HO-2 expres-
of HO-1 mRNA peaked at 3 hours after injection and reached near tosion (N  six in each group). The HO-1 expression was completely
the plateau with further small decreases thereafter until 24 hours later.inhibited by administration of cycloheximide (2 mg/kg) 2 hours before
high-dose SnPP injection (B).
tration of cycloheximide (2 mg/kg) 2 hours before SnPP
injection (Fig. 1B). This result suggests that induction of
HO-1 requires new protein synthesis.
Second, we examined the time course of HO-1 gene
and protein expression in the kidney tissues after high-
dose SnPP injection. The expression of HO-1 mRNA
after injection occurred as early as 30 minutes, peaked
at 3 hours, and reached near to a plateau with further Fig. 3. Time course of heme oxygenase (HO-1) protein synthesis in
the kidney tissues after high-dose tin-protoporphyrin IX (SnPP) (20small decreases thereafter until 24 hours (Fig. 2). The
mol/kg) injection. Expression of HO-1 protein was evaluated by West-expression of HO-1 protein was initially observed 6 hours
ern blot analysis (N  four in each time). -tubulin was used as an
after injection, and enhanced during the periods between internal control. The expression of HO-1 protein was initially observed
6 hours after injection, and enhanced between 12 and 24 hours.12 and 24 hours (Fig. 3).
HO enzyme activity in the whole kidney tissues
Localization of HO-1 protein expression in theHO enzyme activity was measured in the whole kid-
kidney tissuesneys 24 hours after each treatment (Fig. 4). Hemin treat-
ment caused a significant increase in the renal HO activ- Cell-type and spatial expression pattern of HO-1 im-
ity compared with vehicle treatment (P 
 0.05), while munoreactive protein was determined by immunohisto-
either low-dose or high-dose SnPP treatment markedly chemical examination. A marked expression of HO-1
reduced the HO activity below the fresh control level was observed in the proximal and distal tubuli in the
cortex and prominently in the outer strip region of the(P 
 0.01).
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Immunohistochemical expression of ICAM-1 in the
kidney tissues after reperfusion
In immunohistochemistry of vehicle-, hemin- or low-
dose SnPP-treated kidney tissues, ICAM-1–positive ma-
terials were dense in endothelial cells of peritubular capil-
laries within the outer medulla 24 hours after 60 minutes
of warm I/R (Fig. 8 B to D), while few positive ICAM-1
stainings were observed in the sham-operated animals
(Fig. 8A). High-dose SnPP markedly suppressed the re-
nal ICAM-1 expression (Fig. 8E).
Assessment of ED-1–positive cells infiltration in the
kidney tissues after reperfusion
In vehicle-, hemin- or low-dose SnPP-treated kidney
tissues, a pronounced infiltration of ED-1–positive mac-
rophages was observed in the outer medulla 24 hours
Fig. 4. Heme oxygenase (HO) enzyme activity in the whole kidney after warm I/R compared with the sham-operated group
tissues 24 hours after each treatment. Hemin treatment caused a signifi- (Fig. 8 F to I), while high-dose SnPP inhibited the infil-cant increase in renal HO activity compared with vehicle treatment
tration of macrophages (Fig. 8J). The number of infil-(*P 
 0.05), while either low-dose or high-dose tin-protoporphyrin IX
(SnPP) treatment markedly reduced HO activity below the fresh control trating macrophages in the outer medulla 24 hours after
level (**P 
 0.01) (N  six in each group). reperfusion was significantly suppressed to 30.8  4.5/
field of high-dose SnPP-treated kidney tissues (P 
 0.05
vs. vehicle), when compared with 43.2  2.5, 55.4  2.0,
and 47.4  2.9/field of those treated with vehicle, heminouter medulla 24 hours after the high-dose SnPP treat-
or low-dose SnPP, respectively, synchronizing the alter-ment (Fig. 5D), while it was not detected in the tissues
ations of the serum creatinine levels after reperfusionfrom other groups (Fig. 5 A to C).
(Table 1). A significant increase in infiltrating macro-
phages was observed in the hemin-treated group com-Expression of ferritin and HSP 70 in the
pared with the vehicle group (P 
 0.05).kidney tissues
We compared the expression of other protective genes Antiapoptotic effect of high-dose SnPP pretreatment
such as ferritin and HSP 70 in the kidney tissues 24 hours on renal I/R injury
after each treatment. Western blot analysis indicated
TUNEL assay and immunohistochemical staining ofthat there was no significant increase in ferritin and HSP
activated caspase-3 were carried out to examine whether70 expression (Fig. 6).
high-dose SnPP pretreatment has an antiapoptotic effect
on renal I/R injury. At 24 hours after reperfusion, acti-Alterations of serum creatinine levels
vated caspase-3 expression was observed in tubular epi-after reperfusion
thelial cells within the outer medulla in vehicle-, hemin-The serial alterations of the serum creatinine levels
or low-dose SnPP-treated kidney (Fig. 9 B to D), while
were monitored as a sensitive marker of cellular damage
high-dose SnPP treatment significantly decreased the
of reperfused kidneys (Fig. 7). All animals survived for number of activated caspase-3–positive cells compared
7 days after reperfusion. The serum creatinine levels of with vehicle group (Fig. 9E and Table 2). The number
vehicle-treated animals peaked 24 hours after 60 minutes of TUNEL-positive cells was also markedly decreased
of warm I/R and declined thereafter to near the basal in high-dose SnPP group, while hemin treatment signifi-
values until 7 days after reperfusion. Hemin significantly cantly increased TUNEL-positive cells compared with
increased the serum creatinine levels at 1 and 3 days vehicle group (Table 2).
after reperfusion when compared with vehicle control
(P 
 0.05), whereas high-dose SnPP significantly de-
DISCUSSIONcreased the peak levels of serum creatinine (P 
 0.05;
vehicle vs. high-dose SnPP). There was no obvious drug- This study aimed to examine mechanisms by which the
induced cytotoxicity as assessed by the serum creatinine increased expression of HO-1 may attenuate inflamma-
levels in animals free from warm ischemic insult during tory responses after reperfusion of warm ischemically
the period of 7 days after the treatments with 30 to 90 injured kidney. We found that HO-1 protein synthesis
mol/kg of hemin or with 2 to 40 mol/kg of SnPP (data was markedly up-regulated in kidney tissues after prior
administration with high-dose SnPP, which may be asso-not shown).
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Fig. 5. Localization of heme oxygenase (HO-1)–positive materials in the kidney tissues. HO-1–positive materials were not detected in vehicle-
(A), hemin- (B), or low-dose tin-protoporphyrin IX (SnPP)-treated kidney tissues (C ), although a marked expression of HO-1 was observed in
proximal and distal tubuli in the cortex and outer medulla 24 hours after high-dose SnPP treatment (D). Original magnification, 200.
ciated with an earlier recovery from warm ischemic in- uniquely potent capacity for binding to the catalytic site
of HO [17]. The molecular mechanisms by which SnPPjury. In addition, the expression of ICAM-1, the accumu-
lation of macrophages, and apoptotic cell death were stimulates the expression of HO-1 in the kidney tissues
remain unclear. Since the induction of HO-1 by hemereduced in reperfused kidney tissues pretreated with high-
dose SnPP. Because SnPP is a potent competitive inhibi- or heavy metals is believed to occur through a complex
mechanism involving the activation of transcription fac-tor of HO enzyme, the beneficial effect of SnPP may be
mediated via unidentified mechanisms independently of tor such as activator protein-1, SnPP may induce HO-1
at both the transcriptional and translational levels [22].HO activity.
In the present experiment, high-dose SnPP caused There has been much evidence that HO-1 is protective
against oxidative injury in various organs, such as the heart,significant increases in renal HO-1 mRNA and protein
synthesis despite the reduction of HO enzyme activity. liver, lung, or kidney [14, 23–26]. In an in vivo rodent model
of glycerol-induced acute renal failure or cisplatin-inducedSeveral investigators also have shown this paradoxic ob-
servation in lung or liver of SnPP-treated rat [14, 17]. nephropathy, a considerable amount of HO-1 mRNA
and protein synthesis were induced with an increasedInhibition of HO activity by SnPP is so pronounced that,
despite the marked increase in synthesis of new HO-1 HO activity following administration of these pharmaco-
logic drugs, while the inhibition of HO enzyme activityprotein, SnPP completely blocks the activity of both pre-
formed and newly synthesized enzyme because of its by SnPP worsened nephrotoxicity [10, 27]. HO-1 may be
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Fig. 7. Renal function indicated by serum creatinine levels after warm
ischemia and reperfusion (I/R). Mean serum creatinine level in sham-
operated (), vehicle (), hemin (), low-dose tin-protoporphyrin IX
(SnPP) (), or high-dose SnPP group () was presented (N  10 in
each group). High-dose SnPP treatment significantly attenuated an in-
crement in serum creatinine levels after reperfusion compared with
vehicle group, while hemin treatment exacerbated renal injury. *P 

0.05 vs. vehicle control.
Fig. 6. Expression of ferritin and heat shock protein (HSP) 70 in the
SnPP did not inhibit the protective effect [14]. In thekidney tissues 24 hours after each treatment. Expression of ferritin and
HSP 70 protein in kidney tissues was evaluated by Western blot analysis present study, pretreatment of high-dose SnPP attenu-
(A), and the results were expressed as ferritin () or HSP 70 ( )/-tubu- ated renal function following warm I/R despite the de-lin ratios (B) (N  six in each group). There was no significant increase
in ferritin and HSP 70 expression after injection of vehicle, hemin, low- creased HO enzyme activity. These findings indicate that
and high-dose tin-protoporphyrin IX (SnPP). HO enzymatic action is not always associated with bene-
ficial effects of HO-1 and strongly support the presence
of cytoprotective mechanisms that are independent of
HO enzyme activity.a critical protectant against acute glycerol- or cisplatin-
As demonstrated in the present study, hemin pretreat-induced nephrotoxicity. Conceivably, end products of
ment enhanced HO activation but further worsenedHO enzymatic action might account for the protective
warm ischemically damaged renal function when com-effect of HO-1. However, the inhibition of HO activity
pared with vehicle control. In general, free heme is adoes not exacerbate renal function in a model of genta-
pro-oxidant and the toxic effect of heme has been wellmycin-induced nephrotoxicity and HO enzyme activa-
documented [28]. The removal of these harmful mole-tion does not protect against acute renal failure in a rat
cules from cells has been considered to be one of thepostischemic model [10, 11, 27]. Additionally, in fibro-
protective mechanisms of HO-1 induction. However, itblasts derived from HO-1–deficient mice, serum depriva-
has also been suggested that products of heme catabo-tion–induced apoptosis was markedly accentuated as
lism, but not heme itself, may be responsible for thecompared with wild-type fibroblasts, whereas incubation
oxidant activity [29]. Indeed, HO-generated iron releaseof HO-1–deficient fibroblasts with a cyclic guanosine mo-
accounts for heme protein–triggered proximal tubularnophosphate (GMP) analogue, to mimic production of
injury, and HO inhibition by SnPP almost completelycarbon monoxide, or with bilirubin failed to protect
protects proximal tubular cells against myoglobin cyto-against the cell death [9], which indicated that none of
toxicity [30, 31]. In addition, the intracellular iron releasethe products of HO-1 activity account for HO-1’s cyto-
by HO contributes to microsomal lipid peroxidation,protective effect. And further, a previous study has dem-
while SnPP inhibits this pro-oxidant action [32]. Thus,onstrated that intratracheal administration of hemoglo-
the present study suggested that pro-oxidant end prod-bin induces HO-1 in the rat lung and protects against
ucts generated via HO activation might account for thehyperoxic lung injury; interestingly, the protection is not
mediated by increased HO enzyme activity because cytotoxic effect of hemin. In addition to renal expression
Fig. 8. Immunohistochemical expression of intercellular adhesion molecule-1 (ICAM-1) (A to E ) and infiltration of ED-1–positive macrophages
(F to J ) in the outer medulla after warm ischemia and reperfusion (I/R). In immunohistochemistry of vehicle (B), hemin (C), or low-dose tin-
protoporphyrin IX (SnPP) group (D), ICAM-1-positive materials were dense in endothelial cells of peritubular capillaries 24 hours after warm
I/R compared with the sham-operated group (A), while high-dose SnPP markedly suppressed the expression of ICAM-1 (E). A pronounced
infiltration of ED-1–positive macrophages was observed in the outer medulla 24 hours after warm I/R in vehicle (G), hemin (H), or low-dose
SnPP group (I), compared with the sham-operated group (F), while high-dose SnPP obviously inhibited the infiltration of macrophages (J). Original
magnification, 200.
Fig. 9. Activated caspase-3 immunostaining in the outer medulla after warm ischemia and reperfusion (I/R). Although there is no activated
caspase-3–positive cell in sham group (A) at 24 hours after reperfusion, activated caspase-3 expression was observed in tubular epithelial cells
within the outer medulla in vehicle (B), hemin (C ) and low-dose tin-protoporphyrin IX (SnPP) group (D). High-dose SnPP treatment significantly
decreased the number of activated caspase-3–positive cells (E ). Original magnification, 400.
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Table 2. The number of TUNEL- and activated caspase-3–positiveTable 1. Infiltration of ED-1–positive monuclear cells in outer
medulla 24 hours after reperfusion cells in outer medulla 24 hours after reperfusion
Low-dose High-doseLow-dose High-dose
Sham Vehicle Hemin SnPP SnPP Sham Vehicle Hemin SnPP SnPP
TUNEL 0.30.3 16.81.3 28.52.4a 14.31.9 6.51.0a1.80.5 43.22.5 55.42.0a 47.42.9 30.84.5a
Caspase-3 0.50.3 13.81.7 20.82.5 9.52.1 1.30.5aSnPP is tin-protoporphyrin IX. Infiltration of ED-1–positive cells were ex-
pressed as the number of cells per field of view at a magnification of 400. Abbreviations are: TUNEL, terminal deoxynucleotidyl transferase-mediated
aP 
 0.05 vs. vehicle group uridine triphosphate nick end labeling; SnPP, tin-protoporphyrin IX. The positive
stainings of TUNEL and activated caspase-3 were expressed as the number of
positive cells per field of view at a magnification of 200.
a P 
 0.01 vs. vehicle group
of the protective gene HO-1, the inhibition of HO activ-
ity may be associated with the protective effect of high-
dose SnPP treatment on renal I/R injury. tin, and ICAM-1 [43–45], and further reported that HO
Most of the metalloporphyrin tested as HO inhibitors enzyme activation in rat macrophages stimulates the car-
have been found to be rather nonspecific [33]. Indeed, bon monoxide/guanylate cyclase pathway and contrib-
zinc protoporphyrin (ZnPP), a widely used HO inhibitor, utes to the synthesis of proinflammatory genes such as
has been found to inhibit other heme-containing en- tumor necrosis factor- and interleukin-6, while SnPP
zymes, such as guanylate cyclase and nitric oxide syn- inhibits the production of these cytokines [46]. In addition,
thase in some systems [34, 35], and further shown to there is evidence that high-dose SnPP decreases the in-
abolish vascular relaxation in the rat isolated blood ves- flammatory cell number in the exudates in the pleural
sels despite light-exposed ZnPP, which does not inhibit cavity 24 hours after injection of carrageenin [47]. Although
HO enzyme [33]. Therefore, we cannot exclude the pos- it has been speculated that the decrease in inflammatory
sibility that the protective effect of high-dose SnPP treat- cell number might result from a toxic effect of high-dose
ment in our renal I/R model may not be dependent on SnPP, the doses of up to 40 mol/kg SnPP had no toxic
induced HO-1 protein but only associated with nonspe- effect on the renal function of stress-free rats in the
cific effects of SnPP. According to a number of studies, present study (data not shown). Therefore, it is possible
however, SnPP has been found to be rather specific com- that HO-1 protein synthesis induced by high-dose SnPP
pared with other HO inhibitors [36, 37]. Further bio- may be associated with attenuation of ICAM-1 expres-
chemical studies will be required to elucidate the cyto- sion and inhibition of macrophage infiltration, whereas
protective mechanisms of high-dose SnPP treatment HO enzyme activation enhanced by hemin may lead to
against renal I/R injury. infiltration of activated macrophages after reperfusion.
Under several physiologic stresses, HO-1 is concomi- Apoptosis and inflammation are considered to be cen-
tantly induced with other cytoprotective gene expres- tral mechanisms leading to organ damage in the course
sions such as ferritin or HSP 70 [10, 14, 38, 39]. The of renal I/R. Therefore, the inhibition of apoptosis by a
ferritin synthesis is regulated by iron released from heme caspase inhibitor has been reported to prevent renal I/R
degradation and provides a mechanism for coping with injury [48]. Recently, cellular overexpression of HO-1
the potentially toxic nature of iron [40]. The coupling of has been shown to confer marked resistance to apoptosis
ferritin synthesis to HO-1 induction has been reported [49], and moreover, cardioselective overexpression of
to prevent renal failure in rat rhabdomyolysis [10]. HSP HO-1 has been reported to prevent I/R-induced cardiac
70 is also considered to have an antioxidant effect on dysfunction and apoptosis [50]. In the present study, high-
I/R injury [41, 42]. In the present study, no significant dose SnPP pretreatment suppressed the caspase-3 activa-
induction of ferritin or HSP 70 was observed in the kid- tion and decreased the apoptotic cell death. Our results
ney tissues following the administration with hemin or suggest that overexpression of renal HO-1 contributed
high-dose SnPP. Therefore, it is possible that HO-1 ex- to antiapoptotic effects of high-dose SnPP pretreatment,
pression produces protective effects on renal I/R injury which resulted in attenuation of renal I/R injury.
in the absence of other antioxidant protein inductions.
The expression of ICAM-1 and the infiltration of ED-1–
CONCLUSIONpositive macrophages were observed in the outer me-
dulla of the vehicle-treated group after renal I/R. Following In conclusion, relatively high-dose SnPP administra-
tion significantly induces HO-1 protein expression in kid-high-dose SnPP pretreatment, HO-1–positive materials
were prominently expressed in nearly the same region, ney tissues, which leads to attenuation of renal warm
I/R injury; the protection seems not to be mediated bywhich may be most vulnerable to oxidative damage such
as warm I/R [25]. Recent studies have reported that HO-1 heme-degradation pathways, while it may be related to the
down-regulation of proinflammatory cytokines, adhesionhighly expressed in the endothelial cells inhibits the ex-
pression of adhesion molecules such as P-selectin, E-selec- molecules, and apoptotic cell death independently of HO
Kaizu et al: Preconditioning with tin-protoporphyrin IX1402
while markedly increasing content of enzyme protein in liver. Procenzyme activation. Thus, less-toxic SnPP would be po-
Natl Acad Sci USA 84:2464–2468, 1987
tentially applicable to donor preconditioning or pharma- 18. Anderson KE, Simionatto CS, Drummond GS, Kappas A: Tissue
distribution and disposition of tin-protoporphyrin, apotent com-cologic treatment for pathologic conditions that lead to
petitive inhibitor of heme oxygenase. J Pharmacol Exp Ther 228:oxidative insults including I/R.
327–333, 1983
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